Youre working with a clinician, dietitian, or programme that has experience prescribing and supporting Wegovy
Stage 2 (emerging, 2025-2030): Continuous bioprocessing
Research has shown that high levels of TMAO in the blood can contribute to cardiovascular disease
Enhance Performance: Perfect for athletes and fitness enthusiasts
A Critical Analysis of the Clinical Use of Incretin-Based Therapies
At present, several oral antidiabetic medications are used for the treatment of T2DM including, -glucosidases inhibitors, biguanides, sulfonylureas, meglitinides, GLP-1 receptor agonists (GLP-1RAs), peroxisome proliferator-activated receptor (PPAR-) agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, and sodiumglucose transporter 2 (SGLT2) inhibitors